Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × Tamsulosin × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 620 pembrolizumab 500 Paclitaxel 453 Gemcitabine 437 Carboplatin 434 Cisplatin 418 Radiotherapy 379 fludarabine 359 Nivolumab 341 Docetaxel 277 Bevacizumab 274 Irinotecan 256 Magnetic Resonance Spectroscopy 238 Fluorouracil 227 Dexamethasone 224 Capecitabine 218 Specimen Handling 215 Rituximab 204 Cytarabine 201 Oxaliplatin 200 Ipilimumab 198 Temozolomide 197 fludarabine phosphate 194 Biopsy 191 Etoposide 181 Lenalidomide 176 Doxorubicin 174 Leucovorin 172 Injections 170 Cetuximab 170

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04147806 2026-04-03

PROSINT

Albert Einstein College of Medicine

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡